ASX
Clinuvel Pharmaceuticals
CUV:ASX•Healthcare
Sensitive ASX Announcement
Phase III trial of CUV1647 begins in Polymorphic Light Erupt
Published: 21/05/07, 10:04am (AEST)•2 pages